Cytokines and Acute Respiratory Infections

Sepsis

Volumn 1, Issue 3, 1998, Pages 173-179

  Feldman, Charles ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2342447409     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009733224900     Document Type: Article

References (54)

1. Nelson S, Mason CM, Kolls J, Summer WR. Pathophysiology of pneumonia. Clin Chest Med 1995;16:1-12.
2. Mason CM, Nelson S. Pathophysiology of community-acquired pneumonia and treatment strategies based on host-pathogen interactions: the inflammatory interface. Seminars Respir Crit Care Med 1996;17:213-220.
3. Summer RS, Summer WR, Kolls J, Nelson S. Cytokines and pulmonary host defense. Clin Pulm Med 1996;3:129-135.
4. Nicod LP. Cytokines.1. Overview. Thorax 1993;48:660-667.
5. Glauser MP. The inflammatory cytokines. New developments with the pathophysiology and treatment of septic shock. Drugs 1996;52(suppl 2):9-17.
6. Gately MK, Mulqueen MJ. Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases. Drugs 1996;52(suppl 2):18-26.
7. Elias JA, Kotloff R, Prabir R. Cytokines in pulmonary inflammation. In: Fishman AP (ed). Update: Pulmonary Diseases and Disorders. New York: McGraw Hill Inc. 1992; 93-114.
8. Shepherd VL. Cytokine receptors of the lung. Am J Respir Cell Mol Biol 1991;5:403-410.
9. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21:S258-S263.
10. Nelson S, Bagby GJ. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med 1996;17:319-332.
11. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis 1995;172:1061-1071.
12. Dale DC. Granulocyte colony-stimulating factor in infectious diseases. Curr Opin Infec Dis 1993;6:369-373.
13. Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxemia and primate bacteraemia. Surg Gynecol Obstet 1988;166:147-152.
14. Creasey AA, Stevens P, Kenney J, et al. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock 1991;33:84-91.
15. Calandra T, Gerain J, Heumann D, et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991;91:23-30.
16. Dofferhoff ASM, Vellenga E, Limburg PC, et al. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Neth J Med 1991;39:45-62.
17. Waage A, Brandtzaeg P, Espevik T, et al. Current understanding of the pathogenesis of gram-negative shock. Infect Dis Clin North Am 1991;5:781-791.
18. Warren JS. Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 1990;28:38-57.
19. Okusawa S, Gelfand JA, Ikejima T, et al. Interleukin-1 induces a shock-like state in rabbits. J Clin Invest 1988;81: 1162-1172.
20. Ortqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985;17: 377-386.
21. British Thoracic Society. Community-acquired pneumonia in adults in British Hospitals in 1982-83; A BTS/PHLS survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987;62:195-220.
22. Feldman C, Kallenbach JM, Levy H, et al. Community-acquired pneumonia of diverse aetiology: prognostic factors in patients admitted to an intensive care unit and a "severity of illness" score. Intensive Care Med 1989;15:302-307.
23. Fisher E, Marano MA, Van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-1557.
24. van der Poll T, van Deventer SJH, Hack CE, et al. Effects on leucocytes after injection of tumor necrosis factor in healthy humans. Blood 1992;79:693-698.
25. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995;107:1342-1349.
26. Moussa K, Michie HJ, Cree IA, McCafferty AC, Winter JH, Dhillon DP, Stephens S, Brown RA. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 1994;49:107-111.
27. Prins JM, van Deventer SJH, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994;38:1221-1218.
28. Dofferhoff ASM, Potthoff H, Bom VJJ, et al. The release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental gram-negative sepsis. J Endotoxin Res 1995; 2:37-44.
29. Prins JM, Van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double blind study comparing Imipenem and Ceftazidime. J Infect Dis 1995: 172:886-891.
30. Marik P, Kraus P, Scribante J, Havlik I, Lipman J, Johnson DW. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest 1993;104:389-392.
31. Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret M-C, Crestani B, Deschenes M, Trouillet J-L, Aubier M. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150: 710-716.
32. Terashima T, Matsubara H, Nakamura M, Sakamaki F, Waki Y, Soejima K, Tasaka S, Nakamura H, Sayama K, Ishizaka A, Kanazawa M. Local Pseudomonas induces contralateral lung injury and plasma cytokines. Am J Respir Crit Care Med 1996;153:1600-1605.
33. Boutten A, Dehoux MS, Sata N, Ostinelli J, Venembre P, Cretani B, Dombret M-C, Durand G, Aubier M. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336-342.
34. Chollet-Martin S, Montravers P, Gilbert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA. High levels of interleukin 8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993;61:4553-4559.
35. Kragsbjerg P, Jones I, Vikersfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 1995;50:1253-1257.
36. Cosentini R, Blasi F, Imi M, Valenti V, Bregani ER, Ceriani G, Arosio C, Allegra L, Porro F. Interleukin-8 as a predictor of sepsis and septic shock in community-acquired pneumonia. Am J Respir Crit Care Med 1997;155:A929.
37. Rubins JB, Charboneau D, Loch J, Pomeroy C. Role of gamma-interferon in experimental pneumococcal bacteremia. Am J Respir Crit Care Med 1997;155:A802.
38. Nohynek H, Teppo A-M, Laine E, Leinonen M, Eskola J. Serum tumor necrosis factor-α concentrations in children hospitalized for acute lower respiratory tract infection. J Infect Dis 1991;1029-1032.
39. Wilmott RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, Wood RE. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990;142:365-368.
40. Taha RA, Kotsimbos TC, Song Y-L, Menzies D, Hamid Q. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 1997;155: 1135-1139.
41. Kurashima K, Mukaida N, Fujimura M, Yasui M, Nakazumi Y, Matsuda T, Matsushima K. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997;155:1474-1477.
42. Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN. Increased release of interleukin-1 B, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153;799-804.
43. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996;154:594-601.
44. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153:1850-1856.
45. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:602-611.
46. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108:1303-1314.
47. Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995; 108:1315-1325.
48. Meduri GU. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 1996;9:2650-2670.
49. Schutte H, Lohmeyer J, Rosseau S, Ziegler A, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858-1867.
50. Villard J, Dayer-Pastore F, Hamacher J, Aubert JD, Schlegel-Haueter S, Nicod LP. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1549-1554.
51. Christman JW, Holden EP, Blackwell TS. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 1995;23:955-963.
52. Lorente JA, Landin L. Septic shock: potential for modification. Clin Pulm Med 1996;3:150-156.
53. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood 1995;86:1301-1309.
54. Leeper KV, Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995;16:155-171.